Data / Form D filings / MEI Pharma, Inc.
MEI Pharma, Inc.: Form D filings
MEI Pharma, Inc., a pharmaceuticals company in San Diego, CA, filed 2 Form D notices with the SEC between 2011 and 2018. The latest, on May 30, 2018, reports $75 million sold of a $75 million offering to 20 investors.
Find out what MEI Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3611 Valley Centre Drive, SUITE 500, San Diego, CA, 92130
- Phone
- (858) 369-7100
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1262104
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 30, 2018 | New notice | $74,999,990 | $74,999,990 | $0 | 20 | May 15, 2018 | sec.gov |
| May 31, 2011 | New notice | $1,113,344 | $1,113,344 | $0 | 2 | May 16, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frederick W. Driscoll | Director | |
| Christine A. White | Director | |
| David M. Urso | Executive Officer | |
| Nicholas R. Glover | Director | |
| William D. Rueckert | Director | |
| Daniel P. Gold | Executive Officer, Director | |
| Kevan E. Clemens | Director | |
| Thomas C. Reynolds | Director | |
| Robert D. Mass | Executive Officer | |
| Brian G. Drazba | Executive Officer | |
| Charles V. Baltic III | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of May 28, 2018 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what MEI Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.